Unified Airway Disease, An Issue of Otolaryngologic Clinics of North America

The article discusses unified airway disease, a recently defined entity that involves inflammation disease processes in the upper and lower airway and requires co-management by otolaryngologists and allergy immunologists for improved outcomes. The issue provides a comprehensive overview of the pathophysiology, diagnosis, and management of unified airway disease, with 16 practice-oriented topics and in-depth clinical reviews.

Format: Hardback
Length: 240 pages
Publication date: 24 November 2022
Publisher: Elsevier - Health Sciences Division

Unified airway disease, a relatively recent concept, encompasses inflammation-driven disorders affecting the upper and lower respiratory tracts. Collaborative management by otolaryngologists and allergy immunologists often yields favorable outcomes for patients. In this issue, esteemed experts in the field offer a comprehensive examination of unified airway disease, encompassing its pathophysiology, diagnosis, and management from an otolaryngologist's perspective, in collaboration with an allergy-immunology colleague. Spanning 16 practice-oriented topics, this issue delves into environmental factors, eosinophilic disease, non-eosinophilic and granulomatous conditions, cystic fibrosis, pediatric unified airway disease, unified airway disease medical and surgical management, future directions, and more. Furthermore, it includes in-depth clinical reviews, providing actionable insights for clinical practice. Under the guidance of experienced editors, this issue presents the most recent information on unified airway disease, synthesized and distilled from the latest research and practice guidelines to create clinically significant, topic-based reviews.

Weight: 464g
Dimension: 156 x 244 x 18 (mm)
ISBN-13: 9780323939140